相关实验视频
Updated: Jul 5, 2026
06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
9.9K
分享的等离子体代谢物介导代谢性疾病对结肠直肠癌的因果影响:一项双步门德尔随机化研究
Xinyi Shi1, Yuxin Tang1, Yu Zhang1
1School of Science, China Pharmaceutical University, Nanjing 210009, China.
Biomedicines
|October 29, 2025
概括
肥胖和胰岛素抵抗等代谢性疾病因果上会增加结肠直肠癌 (CRC) 的风险,这种风险是由特定的血代谢物介导的. 这项研究确定了关键的代谢物和基因,为CRC预防提供了潜在的治疗点.
科学领域:
- 代谢学 代谢学 代谢学
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
- 流行病学 流行病学
背景情况:
- 结肠直肠癌 (CRC) 与代谢性疾病有关,而血代谢物可能会调解这种关联.
- 了解这些联系对于制定针对性预防和治疗CRC的策略至关重要.
研究的目的:
- 量化代谢性疾病表型与CRC风险之间的遗传相关性和因果关系.
- 为了确定调解代谢疾病和CRC之间的关系的血代谢物.
- 探索下游调节基因和潜在的可药物点.
主要方法:
- 利用链接不平衡得分回归和两个样本的门德尔随机化来评估因果关系.
- 通过两步MR方法分析了1091种血代谢物和309种介导作用的比率.
- 进行了局部化分析,英国生物库验证和基因表达分析 (TCGA,GTEx,GEO).
主要成果:
- 肥胖指标 (BMI,腰围),基础代谢率,胰岛素耐药性和代谢综合征对CRC产生了因果关系.
- 五种血代谢物,包括曼酸和特定比率,被确定为中心调解物.
- 在CRC中观察到FADS1/2/3和FENA基因的上调,FADS1表达与预后较差有关.
结论:
- 这项研究系统地确定了从代谢疾病到CRC的因果途径中的共享血代谢物和调节基因.
- 这些发现突出了CRC生物标志物开发和治疗干预的潜在目标.
- 已识别的代谢物和基因为未来的功能验证和药物发现提供了途径.
相关概念视频
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...